Radioimmunotherapy of colorectal cancer patients with small volume disease:: Results of an ongoing phase-I/II trial.

被引：0
|
作者：
Behr, TM
Liersch, T
Gratz, S
Schmidt, F
Canelo, R
Lorf, T
Post, S
Wörmann, B
Hiddemann, W
Becker, H
Ringe, B
Becker, W
机构：
[1] Univ Gottingen, Dept Nucl Med, D-3400 Gottingen, Germany
[2] Univ Gottingen, Dept Gen Surg, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Transplantat Surg, D-3400 Gottingen, Germany
[4] Univ Gottingen, Dept Hematol Oncol, D-3400 Gottingen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
269
引用
收藏
页码：70P / 70P
页数：1
相关论文
共 50 条
  • [31] PHASE-I TRIAL OF DROLOXIFENE IN PATIENTS WITH METASTATIC BREAST-CANCER
    BUZDAR, AU
    KAU, S
    HORTOBAGYI, GN
    THERIAULT, RL
    BOOSER, D
    HOLMES, FA
    WALTERS, R
    KRAKOFF, IH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (04) : 313 - 316
  • [32] Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial
    Hofheinz, RD
    Hartmann, JT
    Willer, A
    Oechsle, K
    Hartung, G
    Gnad, U
    Saussele, S
    Kreil, S
    Bokemeyer, C
    Hehlmann, R
    Hochhaus, A
    BRITISH JOURNAL OF CANCER, 2004, 91 (05) : 834 - 838
  • [33] Preoperative radioimmunochemotherapy with cetuximab and 5-FU in patients with advanced rectal cancer - First results of a phase-I/II-trial
    Semrau, R.
    Vallbohmer, D.
    Kocher, M.
    Lux, S.
    Metzger, R.
    Schneider, P.
    Holscher, A. H.
    Muller, R. -P.
    ONKOLOGIE, 2008, 31 : 92 - 93
  • [34] VOLUME REQUIREMENTS FOR THE TREATMENT OF HYPOTENSION DURING A PHASE-I TRIAL OF TUMOR NECROSIS FACTOR IN CANCER-PATIENTS
    LOGAN, TF
    KIRKWOOD, JM
    ERNSTOFF, MS
    KOWAL, CD
    KUCHARSKI, C
    HOEBLER, L
    WOOD, D
    NADLER, P
    CLINICAL RESEARCH, 1988, 36 (03): : A497 - A497
  • [35] Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC):: A phase I/II trial.
    Sanchez, J. M.
    Mellemgaard, A.
    Perry, M.
    Zatloukal, P.
    Hamm, J.
    Belani, C. P.
    Kim, E.
    Felip, E.
    Berton, M.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 390S - 390S
  • [36] UFT plus leucovorin (LV) in advanced colorectal cancer (CCR).: A phase II trial.
    Aranda, E
    Antón-Torres, A
    Sastre, J
    Navarro, M
    Rivera, F
    Carrato, A
    Bretón, JJ
    Grávalos, C
    Aparicio, J
    Fernandez-Martos, C
    Díaz-Rubio, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S79 - S79
  • [37] Phase I radioimmunotherapy trial of 131I-huA33 in patients with advanced colorectal carcinoma.
    Chong, G
    Lee, F
    Hopkins, W
    Mountain, A
    Potasz, N
    Murphy, R
    Chappell, B
    Schleyer, P
    Papenfus, T
    O'Keefe, GJ
    Cebon, PUJ
    Mitchell, P
    Poon, A
    Burgess, AW
    Hoffman, E
    Old, LJ
    Scott, AM
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 32P - 32P
  • [38] Amifostine promotes multilineage hematopoiesis in patients with myelodysplastic syndrome (MDS): Results of a phase I/II clinical trial.
    List, AF
    Heaton, R
    GlinsmannGibson, B
    Brasfield, F
    Crook, L
    Chartrand, C
    Taetle, R
    Kurman, M
    BLOOD, 1996, 88 (10) : 1802 - 1802
  • [39] Phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: Preliminary results of an ongoing study
    Natale, RB
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 34 - 37
  • [40] Initial results of an ongoing trial of combined radioimmunotherapy (RAIT) and chemotherapy (CH) in patients with medullary thyroid cancer (MTC).
    Juweid, M
    Rubin, AD
    Hajjar, G
    Stein, R
    Sharkey, RM
    Goldenberg, DM
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 54P - 54P
12345